Fig. 1From: Pegylated liposomal doxorubicin (Lipo-Dox®) combined with cyclophosphamide and 5-fluorouracil is effective and safe as salvage chemotherapy in taxane-treated metastatic breast cancer: an open-label, multi-center, non-comparative phase II study(a) Progression free survival (PFS) and (b) Overall survival (OS) of intent-to-treat (ITT) patients. The median PFS was 8.2 months, and the median OS was 36.6 monthsBack to article page